P&G Stannous Fluoride Data Support "Restricted" Plaque Claim - FDA Cmte.
This article was originally published in The Tan Sheet
Executive Summary
Data on stannous fluoride-containing dentrifices support the use of "restricted" antiplaque claims on product labeling, FDA's Nonprescription Drugs Advisory Committee Dental Plaque Subcommittee recommended during its meeting in Silver Spring, Md. Oct. 22. The panel voted 5-0 in favor of recommending the claim to FDA.